Dow licenses NRC’s pathogen-fighting technology

Guest Contributor
December 11, 2003

Dow AgroSciences has obtained worldwide licensing rights from the National Research Council (NRC) to market technologies that reduce the risk of food-borne pathogens. The agreement gives the company exclusive rights to specific antibody technologies that are being developed under a 2001 collaborative agreement between Dow AgroSciences Canada and NRC’s Institute for Biological Sciences in Ottawa. The company says the collaboration has already developed inventions that hold great promise in combating two of the most common food-related health threats, E coli O157:H7 in cattle and Campylobacter jejuni in poultry.


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.